Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Malone

Showing results (51-60 of 239) with videos related to

Pageof 24
Sort By:
The American Journal of Geriatric Pharmacotherapy|October 16, 2012
Racial and ethnic disparities in Alzheimer's disease pharmacotherapy exposure: an analysis across four state Medicaid populationsAdrienne M Gilligan, Daniel C Malone, Terri L Warholak, et al.
Pharmacotherapy|June 5, 2007
Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care SystemWei-Shi Yeh, Edward P Armstrong, Grant H Skrepnek, et al.
The Annals of Pharmacotherapy|April 20, 2006
Performance of drug-drug interaction software for personal digital assistantsNatalie A Perkins, John E Murphy, Daniel C Malone, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 5, 2008
Relationship between pharmaceutical services characteristics and exposure rates to drug-drug interactions in Veterans Affairs medical centersMaysaa H Mahmood, Edward P Armstrong, Daniel C Malone, et al.
Rheumatology International|September 14, 2022
Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposureMalinda S Tan, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
Antihypertensive Drug Utilization in Hypertensive Veterans With Complex Medication ProfilesBarry L. Carter, Daniel C. Malone, Sam L. Ellis, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 7, 2011
Critical issues associated with drug-drug interactions: highlights of a multistakeholder conferenceLisa E Hines, John E Murphy, Amy J Grizzle, et al.
Journal of Managed Care Pharmacy : JMCP|July 7, 2005
Consumer understanding and satisfaction associated with a 3-tier prescription drug benefitBridget M Olson, Daniel C Malone, Woodie M Zachary, et al.
Journal of Medical Economics|April 7, 2023
Assessing the impact of single or short-term administration on a therapy's cost-effectiveness: a hypothetical disease-agnostic modelAlexa C Klimchak, Lauren E Sedita, Katherine L Gooch, et al.
Epilepsy & Behavior : E&B|February 8, 2018
Economic impact of epilepsy and the cost of nonadherence to antiepileptic drugs in older Medicare beneficiariesQueeny Ip, Daniel C Malone, Jenny Chong, et al.
Pageof 24

Showing results (51-60 of 239) with videos related to

Sort By:
Pageof 24
The American Journal of Geriatric Pharmacotherapy|October 16, 2012
Racial and ethnic disparities in Alzheimer's disease pharmacotherapy exposure: an analysis across four state Medicaid populationsAdrienne M Gilligan, Daniel C Malone, Terri L Warholak, et al.
Pharmacotherapy|June 5, 2007
Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care SystemWei-Shi Yeh, Edward P Armstrong, Grant H Skrepnek, et al.
The Annals of Pharmacotherapy|April 20, 2006
Performance of drug-drug interaction software for personal digital assistantsNatalie A Perkins, John E Murphy, Daniel C Malone, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 5, 2008
Relationship between pharmaceutical services characteristics and exposure rates to drug-drug interactions in Veterans Affairs medical centersMaysaa H Mahmood, Edward P Armstrong, Daniel C Malone, et al.
Rheumatology International|September 14, 2022
Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposureMalinda S Tan, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
Antihypertensive Drug Utilization in Hypertensive Veterans With Complex Medication ProfilesBarry L. Carter, Daniel C. Malone, Sam L. Ellis, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 7, 2011
Critical issues associated with drug-drug interactions: highlights of a multistakeholder conferenceLisa E Hines, John E Murphy, Amy J Grizzle, et al.
Journal of Managed Care Pharmacy : JMCP|July 7, 2005
Consumer understanding and satisfaction associated with a 3-tier prescription drug benefitBridget M Olson, Daniel C Malone, Woodie M Zachary, et al.
Journal of Medical Economics|April 7, 2023
Assessing the impact of single or short-term administration on a therapy's cost-effectiveness: a hypothetical disease-agnostic modelAlexa C Klimchak, Lauren E Sedita, Katherine L Gooch, et al.
Epilepsy & Behavior : E&B|February 8, 2018
Economic impact of epilepsy and the cost of nonadherence to antiepileptic drugs in older Medicare beneficiariesQueeny Ip, Daniel C Malone, Jenny Chong, et al.
Pageof 24